Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Silvadene
Drug ID BADD_D02022
Description Silver sulfadiazine is a sulfa derivative topical antibacterial used primarily on second- and third-degree burns.
Indications and Usage Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.
Marketing Status approved; vet_approved
ATC Code D06BA01
DrugBank ID DB05245
KEGG ID D00433
MeSH ID D012837
PubChem ID 5214
TTD Drug ID D08JCA
NDC Product Code 59762-0131; 76420-208; 61919-237; 63187-023; 63629-8769; 43898-0134; 53002-9090; 63629-8773; 70518-1562; 82098-008; 51552-0965; 61570-131; 50090-0717; 63629-8768; 63629-8770; 63629-8772; 76003-1056; 50090-0607; 66267-943; 68071-2804; 80425-0221; 53002-9091; 63629-8771; 67877-124; 68788-0600; 68788-8074; 70518-2373; 11722-021; 55700-640; 49452-6545; 43598-210; 45865-642; 73379-002; 50090-0230; 50090-0763
UNII Not Available
Synonyms Silver Sulfadiazine | Sulfadiazine, Silver | Sulfafdiazine, Silver | Silver Sulfafdiazine | Dermazin | Flamazine | Flammazine | Sicazine | Thermazene | Silvederma | SSD | SSD AF | Sulfargen | Brandiazin | Silvadene
Chemical Information
Molecular Formula C10H12AgN4O2S+3
CAS Registry Number 22199-08-2
SMILES C1=CN=C(N=C1)[NH2+]S(=[OH+])(=O)C2=CC=C(C=C2)N.[Ag+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agranulocytosis01.02.03.001--Not Available
Aplastic anaemia01.03.03.002--Not Available
Bacterial disease carrier11.07.03.001--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Erythema multiforme23.03.01.003; 10.01.03.015--
Gastrointestinal disorder07.11.01.001--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Hepatic necrosis09.01.07.002--
Hepatitis09.01.07.004--Not Available
Hypersensitivity10.01.03.003--
Leukopenia01.02.02.001--Not Available
Nephrotic syndrome20.05.01.002--
Rash23.03.13.001--Not Available
Sepsis11.01.11.003--
Skin discolouration23.03.03.005--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin necrosis23.03.03.011--Not Available
Stevens-Johnson syndrome10.01.01.045; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Thrombocytopenia01.08.01.002--Not Available
Tubulointerstitial nephritis20.05.02.002--Not Available
Blood disorder01.05.01.004--Not Available
Muscle contracture15.03.05.024--Not Available
Partner stress26.04.01.002--Not Available
The 1th Page    1    Total 1 Pages